These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7241459)

  • 1. Effects of phenoxybenzamine on bladder neck opening.
    Waterfall NB; Williams G
    J R Soc Med; 1980 May; 73(5):345-7. PubMed ID: 7241459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenoxybenzamine for symptoms of bladder neck obstruction.
    Drug Ther Bull; 1983 Feb; 21(4):15-6. PubMed ID: 6187524
    [No Abstract]   [Full Text] [Related]  

  • 3. Bladder outflow obstruction treated with phenoxybenzamine.
    Abrams PH; Shah PJ; Stone R; Choa RG
    Prog Clin Biol Res; 1981; 78():269-75. PubMed ID: 6174998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bladder outflow obstruction treated with phenoxybenzamine.
    Abrams PH; Shah PJ; Stone R; Choa RG
    Br J Urol; 1982 Oct; 54(5):527-30. PubMed ID: 6184106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenoxybenzamine reduces bladder outlet obstruction in benign prostatic hyperplasia. A urodynamic investigation.
    Gerstenberg T; Blaabjerg J; Nielsen ML; Clausen S
    Invest Urol; 1980 Jul; 18(1):29-31. PubMed ID: 6157651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary bladder neck obstruction in patients with urethral valves: Treatment with phenoxybenzamine.
    McGuire EJ; Weiss RM
    Urology; 1975 Jun; 5(6):756-8. PubMed ID: 1136085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenoxybenzamine for benign prostatic obstruction. Review of 200 cases.
    Caine M; Perlberg S; Shapiro A
    Urology; 1981 Jun; 17(6):542-6. PubMed ID: 6166111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A placebo-controlled double-blind study of the effect of phenoxybenzamine in benign prostatic obstruction.
    Caine M; Perlberg S; Meretyk S
    Br J Urol; 1978 Dec; 50(7):551-4. PubMed ID: 88984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Urodynamic study of lower urinary tract. VI. Clinical application of alpha adrenergic blocker for the treatment of benign prostatic hypertrophy and bladder neck contracture (author's transl)].
    Kondo A; Narita H; Otani T; Kobayashi M; Takita T
    Nihon Hinyokika Gakkai Zasshi; 1978 Oct; 69(10):1232-40. PubMed ID: 83419
    [No Abstract]   [Full Text] [Related]  

  • 10. Functional bladder neck obstruction: a rare cause of renal failure.
    Kumar A; Banerjee GK; Goel MC; Mishra VK; Kapoor R; Bhandari M
    J Urol; 1995 Jul; 154(1):186-9. PubMed ID: 7776419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bladder outflow obstruction treated with phenoxybenzamine. Preliminary note.
    Abrams P; Hollister P; Lawrence J; Doyle PT; Sherwood T; Whitaker RH
    Br J Urol; 1982 Oct; 54(5):530. PubMed ID: 6184107
    [No Abstract]   [Full Text] [Related]  

  • 12. [Alpha adrenergic blocking agents in disorders of the bladder sphincter].
    Perrigot M; Vannier A; Bor Y
    Rev Prat; 1986 Jan; 36(5):223-8. PubMed ID: 2421393
    [No Abstract]   [Full Text] [Related]  

  • 13. Functional bladder neck obstruction in males: a progressive disorder?
    Mishra VK; Kumar A; Kapoor R; Srivastava A; Bhandari M
    Eur Urol; 1992; 22(2):123-9. PubMed ID: 1478227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of neurogenic bladder dysfunction in the adult.
    Wein AJ; Raezer DM; Benson GS
    Urology; 1976 Nov; 8(5):432-43. PubMed ID: 790744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenoxybenzamine in neurogenic bladder dysfunction after spinal cord injury. I. Voiding dysfunction.
    Scott MB; Morrow JW
    J Urol; 1978 Apr; 119(4):480-2. PubMed ID: 650749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Personal experiences with phenoxybenzamine (Dibenzyran) in the treatment of functional disorders of bladder emptying].
    Wehnert J; Sage S
    Z Urol Nephrol; 1988 Mar; 81(3):153-8. PubMed ID: 3388995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Urological complications in patients with multiple sclerosis (author's transl)].
    Kiesswetter H; Flamm J; Hennrich F; Summer K; Schober W
    Wien Klin Wochenschr; 1980 Jan; 92(1):16-22. PubMed ID: 6929626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased urinary nerve growth factor reflects prostatic volume reduction and relief of outlet obstruction in patients with benign prostatic enlargement treated with dutasteride.
    Wada N; Matsumoto S; Kita M; Hashizume K; Kakizaki H
    Int J Urol; 2014 Dec; 21(12):1258-62. PubMed ID: 25039474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-adrenergic agents in urinary disorders of the proximal urethra. Part II. Urethral obstruction due to "sympathetic dyssynergia".
    Awad SA; Downie JW; Kiruluta HG
    Br J Urol; 1978 Aug; 50(5):336-9. PubMed ID: 37973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraprostatic and bladder-neck injection of botulinum A toxin in treatment of males with bladder-neck dyssynergia: a pilot study.
    Lim SK; Quek PL
    Eur Urol; 2008 Mar; 53(3):620-5. PubMed ID: 17950522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.